Literature DB >> 19688403

Validation of prognostic scoring systems for patients undergoing resection of colorectal cancer liver metastases.

Christoph Reissfelder1, Nuh N Rahbari, Moritz Koch, Alexis Ulrich, Isabel Pfeilschifter, Anke Waltert, Sascha A Müller, Peter Schemmer, Markus W Büchler, Jürgen Weitz.   

Abstract

BACKGROUND: Several prognostic scoring systems have been established for patients undergoing resection of colorectal cancer (CRC) liver metastases; however, comparative analyses of their prognostic relevance is still lacking in the literature. The aim of the present study was to assess the predictive value of five published scoring systems in an independent patient cohort for the purpose of external validation.
METHODS: A total of 281 patients underwent liver resection for CRC liver metastases at our institution between January 2002 and January 2008. The predictive value of the Nordlinger score, Memorial Sloan-Kettering Cancer Center (MSKCC) score, Iwatsuki score, Basingstoke index, and Mayo scoring system was assessed in this patient set. Furthermore, clinical and pathologic parameters included in the assessed scoring systems were analyzed by means of univariate and multivariate analyses.
RESULTS: The disease-specific survival at 1, 3, and 5 years was 94.6%, 61.8%, and 33.7%, respectively. Of the assessed scoring systems, only the MSKCC score (P = .006) and the Iwatsuki score (P = .01) provided a statistically significant stratification of patients with regard to survival. The predictive value was particularly evident for patients grouped within the high-risk categories. None of these patients was alive at 3 years after surgery. The 3-year survival rates for high-risk patients in the remaining three scoring systems was > 50%.
CONCLUSIONS: In our patient cohort, survival was only predicted by MSKCC and Iwatsuki scores. These findings highlight the importance of validating scoring systems in independent patient groups.

Entities:  

Mesh:

Year:  2009        PMID: 19688403     DOI: 10.1245/s10434-009-0654-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  38 in total

1.  The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.

Authors:  Teresa Schreckenbach; Patrizia Malkomes; Wolf O Bechstein; Guido Woeste; Andreas A Schnitzbauer; Frank Ulrich
Journal:  Surg Today       Date:  2015-01-07       Impact factor: 2.549

2.  Transection of the liver parenchyma with an ultrasound dissector or a stapler device: results of a randomized clinical study.

Authors:  Mats Savlid; Angelica Horna Strand; Anders Jansson; Thorhallur Agustsson; Gunnar Söderdahl; Lars Lundell; Bengt Isaksson
Journal:  World J Surg       Date:  2013-04       Impact factor: 3.352

3.  Comparison of various surgical approaches for extensive bilateral colorectal liver metastases.

Authors:  Christoph Reissfelder; Nuh N Rahbari; L Urrutia Bejarano; Thomas Schmidt; Nikolas Kortes; Hans-Ulrich Kauczor; Markus W Büchler; Jürgen Weitz; Moritz Koch
Journal:  Langenbecks Arch Surg       Date:  2014-03-11       Impact factor: 3.445

Review 4.  Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes.

Authors:  William J Hadden; Philip R de Reuver; Kai Brown; Anubhav Mittal; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

5.  Strong YB-1 expression predicts liver recurrence following resection for colorectal metastases.

Authors:  Francesco Ardito; Vincenzo Arena; Maria Vellone; Gennaro Grande; Ilaria Pennacchia; Francesco Majellaro; Ivo Giovannini; Fabio M Vecchio; Gennaro Nuzzo; Felice Giuliante
Journal:  J Gastrointest Surg       Date:  2014-09-18       Impact factor: 3.452

6.  Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases.

Authors:  Giovanni Brandi; Jody Corbelli; Francesco de Rosa; Stefania Di Girolamo; Ciro Longobardi; Valentina Agostini; Ingrid Garajová; Stefano La Rovere; Giorgio Ercolani; Gian Luca Grazi; Antonio Daniele Pinna; Guido Biasco
Journal:  Langenbecks Arch Surg       Date:  2012-06-19       Impact factor: 3.445

7.  Combined therapeutic efficacy of 188Re-liposomes and sorafenib in an experimental colorectal cancer liver metastasis model by intrasplenic injection of C26-luc murine colon cancer cells.

Authors:  Ya-Jen Chang; Wei-Hsin Hsu; Chih-Hsien Chang; Keng-Li Lan; Gann Ting; Te-Wei Lee
Journal:  Mol Clin Oncol       Date:  2014-01-20

8.  PRIMARY TUMOR LYMPHOVASCULAR INVASION NEGATIVELY AFFECTS SURVIVAL AFTER COLORECTAL LIVER METASTASIS RESECTION?

Authors:  Renato Gomes Campanati; João Bernardo Sancio; Lucas Mauro de Andrade Sucena; Marcelo Dias Sanches; Vivian Resende
Journal:  Arq Bras Cir Dig       Date:  2021-06-11

9.  [Neoadjuvant chemotherapy or primary surgery for colorectal liver metastases. Pro adjuvant chemotherapy].

Authors:  F Lordick; M Knödler; U Hacker; M Bartels
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

Review 10.  Surgery for colorectal liver metastases: The evolution of determining prognosis.

Authors:  Gaya Spolverato; Aslam Ejaz; Nilo Azad; Timothy M Pawlik
Journal:  World J Gastrointest Oncol       Date:  2013-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.